Что делать при обнаружении вреда, причиненного лекарственными препаратами?

1. <div><p>Воробьев П. А. Перечень жизненно необходимых и важнейших лекарственных средств — что делать? Пробл. стандарт, здравоохр., 2004, II, 3-11.</p><p>Ernst Е., Pittler М. Н. Assessment of therapeutic safety in systemic reviews:literature review. BMJ, 2001, 323, 546.</p><p>Note for guidance on clinical safety data management.definitions and standards for expedited reporting. С PM P/ICH/377/95.</p><p>Cobert B. L., Biron P. Pharmacovigilancefrom A to Z. Malden M. A.:Blackwell Science, 2002.</p><p>Бродецкая К. А. Влияние лефлуномида на активность и прогрессирование ревматоидного артрита. Автореф. дисс. кмн., М., 2004, 27с.</p><p>Основы клинической фармакологии и рациональной фармакотерапии:Рук. для практикующих врачей. Под общ. ред Ю. Б. Белоусова, М. В. Леоновой, М., Бионика, 2002, 368.</p><p>Deeks J. J., Smith L. A., Bradley М. D. Efficacy, tol- erability, and upper gastrointestinal safety ofcelecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials. BMJ, 2002, 325, 619</p><p>Bates D. W, Cullen D. J., Laird N. et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Gmup. JAMA, 1995, 274, 29-34.</p><p>Gurwitz J. H., Field T. S., Avorn J. et al. Incidence and preventability of adverse drug events in nursing homes. Am. J. Med., 2000, 109, 87-94.</p><p>Gaqndhi Т. K., Weingart S. N. BorusJ. et at. Adverse drug events in ambulatoryvcare. N. Engl. J. Med., 2003, 348, 1556-1564.</p><p>Kauslial R., Bates D. W., Landrigan C. et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001, 285, 2114-2120.</p><p>Bates D. W., Spell N., Cullen D. J. The cost of adverse drug events in hospitalized patients. Adverse drug events prevention study group. JAMA, 1997, 277, 307-311.</p><p>Gandhi Т. К, Burstin Н. R., Cook Е. F. et al. Drug complications in outpatients. J. Gen. Intern. Med., 2000, 15, 149-154.</p><p>Nebeker J. R., Barach P., Samore M. Y. Clarifying adverse drug eventy.a clinician’s guide to terminology, documentation, and reporting. Ann. Intern. Med., 2004, 140, 795-801.</p><p>Guideline for postmarketing reporting of adverse drug experiences. Rockvile, MD:US Food and Drug Administration, 1992.</p><p>Kohn L. Т., Corrigan J. М. Donaldson M. S. To Err is Human:Building a safer Health System. Washington, DC.National Academy Pr, 1999.</p><p>Classen D. C., Pestotnik S. L., Evans R. S., Burke J. P. Computerized surveillance of adverse drug events in hospital patients. JAMA, 1991, 266, 2847-2851.</p><p>Andrews L. B., Stocking C., Krizek T. et al. An flter- native strategy for studying adverse events in medical care. Lancet, 1997, 349, 309-313.</p><p>Lazarou J. Pomeranz В. H. Corey P. N. Incidence of adverse drug reactions in hospitalized patients.a metaanalysis of prospective studies. JAMA, 1998, 279, 1200-1205.</p><p>Tanne J. H. The new word in designer drugs. BMJ, 1998, 316, 1930.</p><p>Veivloet D. Durham S. ABC of allergies.adverse reactions to drugs. BMJ, 1998,316, 1511-1514.</p><p>Khan S. H. Description of adverse drug events should be standardized. BMJ, 1999, 318, 127.</p><p>Lucas L. М., Colley C. A. Recognizing and reporting adverse drug reaction. West.J. Med., 1992, 156, 172175.</p><p>Wood A. J., Stein С. М., Woosley R. Making medicines safer - the need for an independent drug safety board. N. Engl. J. Med., 1998, 339, 1851-1854.</p><p>Ladewski L. A., Belknap S. М., Nebeker J. R. et al. Dissemination of information on potentially fatal adverse drug reaction for cancer drug from 2000 to 2002:first results from the research on adverse drug events and reports project. J. Clin. Oncol., 2003, 21, 3859-3866.</p><p>Pirmohamed М., Breckenridge A. М., Kitteringham N. R., Park ВK. Fortnighty review:Adverse drug reac- tuins. BMJ, 1998, 316, 1295-1298.</p><p>Moore N., Lecointre D., Noblet C., Mabille M. Frequency and cost of series adverse drug reactions in a department of general medicine. Br. J. Clin. Pharmacol., 1998, 45, 301-308.</p><p>Hardmeier B., Braunschweig S., Cavallaro M. et al. Adverse drug events caused by medication errors in medical inpatients. Swiss. Med. Wkly, 2004, 134, 664670.</p><p>Bates D. W. Boyle D. L. Vander Vliet М. B. et at Relationship between medication errors and adverse drug events. J. Gen. Intern. Med., 1995, 10, 199-205.</p><p>Morimoto Т., Gandhi Т. A'., Seger A. C. et al. Adverse drug events and medication errors:detection and classification methods. Qual. Saf. Health Care, 2004, 13, 306-314.</p><p>Barker K. N., Flynn E. A., Pepper G. A. et al. Medication errors observed in 36 health care facilities. Arch. Intern. Med., 2002, 162, 1897-1903.</p><p>Bates D. W. Medication errors. How common are they and what can be done to prevent them ?Drug Saf, 1996, 15, 303-310.</p><p>SchaafT., Van der Lucas D. A., Hale A. R, eds. Near Miss Reporting as a safety tool. Oxford:Butterworth- Heinemann, 1991.</p></div><br />